The following 2018/19 innovations have been extended for a further 12 months from 1 April 2019:
- HeartFlow – Advanced image analysis software that creates a 3D model of the coronary arteries and analyses the impact that blockages have on blood flow to rapidly diagnose patients with suspected coronary artery disease. The use of the device can avoid the need for invasive investigations such as coronary angiography, usually carried out under local anaesthetic, where a catheter is passed through the blood vessels to the heart to release a dye before X-rays are taken. NICE estimate up to 35,000 people per year could be eligible.
- Plus Sutures – A new type of surgical suture – stitching – that reduces the rate of surgery-linked infection (surgical site infection) such as MRSA, through the use of antimicrobial suture packs. A total of 846 cases of MRSA bacteremia were reported by acute NHS Trusts in England between 1 April 2017 and 31 March 2018.
- Endocuff Vision – A medical device which attaches to the distal end of an endoscope that improves colorectal examination for patients undergoing bowel cancer tests. Bowel cancer is the fourth most common cancer in England with 34,000 people diagnosed each year. For every 1,000 people screened for cancer, it is estimated that six cases could be avoided thanks to early detection using this device.
- SecurAcath – A device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter. The use of this equipment helps to reduce the time taken to care and treat dressing changes. This type of catheter is normally used in people needing intravenous access for several weeks or months in both inpatient and outpatient settings. NICE estimate up to 120,000 people per year could be eligible.
Additionally, for a further 12-month period from 1 April 2019 NHS England supports DrDoctor, a digital tool to help patients’ view, change and schedule appointments, to demonstrate its potential in a real-world setting.
- The Innovation and Technology Payment (ITP) 2018/19 builds on the Innovation and Technology Tariff (ITT). It supports the NHS in adopting innovation by removing some of the financial or procurement barriers which can inhibit uptake at scale.
- It is a competitive process designed to scale up adoption of innovations and technologies that have already proved their clinical effectiveness and are ready for nationwide spread.
- The ITP’s focus is to support a range of cost effective medical devices, digital platforms and technologies within our budgetary confines and will have a wide-reaching impact on patient care, deliver savings to the NHS and maximise learning from the programme while fostering culture change.
- The ITP programme forms part of a wider set of activities to support innovation in the NHS, led by NHS England and delivered with the support of the Academic Health Science Network.
- The implementation of any agreed payment mechanism or procurement became operational on 1st April 2018 and will cease 31st March 2020.
- Day-to-day support and reporting will be via NHS England’s Innovation, Research and Life Sciences Unit.
Technical notes will be incorporated within the ITP 2019/20 document located on the ITP 2019/20 page during June.